Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特区 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Middle East and North Africa
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Portugal
Paraguay
Perú (Peru)
Polska (Poland)
Российская Федерация (Russia)
Puerto Rico
Romania
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
Southeast Asia
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台湾地区 (Taiwan)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Medtronic stories
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 8, 2021
Medtronic Diabetes business advances global pediatric strategy
-
Nov 23, 2021
For Diabetes Awareness Month and World Diabetes Day, Medtronic is celebrating the discovery of insulin and other treatments making life easier for people living with the condition.
-
Nov 23, 2021
Company continued to launch new products, win share, and deliver strong earnings growth; market procedure volumes impacted by COVID-19 resurgence
-
Nov 17, 2021
Since the Micra Transcatheter Pacing System (TPS) received pre-market approval in 2016, Medtronic has worked with the FDA to continuously monitor the safety and effectiveness of this novel...
-
Nov 15, 2021
The Society of Women Engineers awards Medtronic and Engineering Director Jim Borowick for ongoing contributions to diversity and inclusion
Stories published to our news archive may contain outdated information or links that are no longer active. Please note we do not update stories once they have been moved to the archive. Access and use the information in the stories at your own discretion.